Gain Therapeutics announces Phase 1b clinical trial approval in Australia for GT-02287 to evaluate safety in Parkinson's disease patients. Gain Therapeutics, Inc. has received approval to start ...

PARKINSONS Australia is encouraging people to participate in a nationwide survey aimed at supporting the education of health ...

Australian researchers have made a huge breakthrough in the fight against Parkinson's disease after solving a decades-long mystery. Scientists at the Walter and Eliza Hall Institute of Medical ...

A new international study points to a specific brain network as the core driver of Parkinson’s disease. Scientists found that ...

Bridging the divide between Parkinson scientists and the Parkinson community At the heart of our work is connection: ...

This article explores the significance of local support networks, the challenges of living with Parkinson’s, and how Noosa is making strides in improving the quality of life for its residents. Often ...

Parkinson's disease does more than cause tremor and trouble walking. It can also affect sleep, smell, digestion and even thinking. That may be because the disease disrupts communication in a brain ...

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and how to ...